Results 111 to 120 of about 13,840,459 (217)

Quality of life in patients with neovascular age-related macular degeneration before and after intravitreal therapy: a longitudinal observational study

Frontiers in Medicine
BackgroundAge-related macular degeneration is a chronic and progressive disease that typically develops after the age of 50. Characterized by visual distortions, image blurring, and gradual central vision loss, age-related macular degeneration ...
Marta Nowak, Anna Maria Cybulska, Aleksandra Derezińska, Elżbieta Grochans, Mariusz Panczyk, Katarzyna Kęcka, Kamila Rachubińska   +6 more
doaj   +1 more source

Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes

, 2016
Ana Catarina Pedrosa,1 Adriana Reis-Silva,2 João Pinheiro-Costa,1,3 João Beato,1 Paulo Freitas-da-Costa,1,3 Manuel S Falcão,1,2 Fernando Falcão-Reis,1,2 Ângela Carneiro1,2 1Department of Ophthalmology, Hospital de S ...
Beato J, Pedrosa AC, Falcão-Reis F, Freitas-da-Costa P, Reis-Silva A, Falcão MS, Carneiro A, Pinheiro-Costa J   +7 more
core  

All Types of Age-related Macular Degeneration in One Patient

, 2017
Herein, we describe a neovascular age-related macular degeneration patient with retinal angiomatous proliferation (RAP) and polypoidal choroidal vasculopathy (PCV) coexisting in the same eye at the time of diagnosis.
Zafer Cebeci, Nur Kır, Cebeci, Zafer, Kir, Nur   +3 more
core   +1 more source

Age-related macular degeneration

, 2014
Age-related macular degeneration (AMD) is a disease of the retina that usually develops in people aged 60 years and older. It affects about 8.7% of the world’s population and is the leading cause of blindness among people aged 50 and older in ...
Wanjiku Mathenge
core  

Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-related Macular Degeneration: Twelve-month MONT BLANC Study Results

, 2012
To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular ...
Larsen, Michael, Tokaji, Erika, Weisberger, Annemarie, Pilz, Stefan, Schmidt-Erfurth, Ursula, MONT BLANC Study Group,, Lanzetta, Paolo, Simader, Christian, Wolf, Sebastian, Tokaji E, Wolf S, Simader C, Pilz S, MONT BLANC Study Group, Larsen M, Weisberger A., Schmidt Erfurth U   +16 more
core   +1 more source

Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab

Pharmaceuticals
Our objective was to evaluate changes in patient-reported outcome measures using the NEI-VFQ 25 questionnaire during a treat and extend regimen in naive neovascular Age-Related Macular Degeneration patients, and its correlation with anatomical and ...
Pablo Almuiña-Varela, Laura García-Quintanilla, María José Rodríguez-Cid, María Gil-Martínez, Maximino J. Abraldes, Francisco Gómez-Ulla, Ana Estany-Gestal, Jorge Miguel Alcántara-Espinosa, Maribel Fernández-Rodríguez, Anxo Fernández-Ferreiro   +9 more
doaj   +1 more source

Ranibizumab versus verteporfin for neovascular age-related macular degeneration

, 2006
BACKGROUND: We compared ranibizumab--a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of vascular endothelial growth factor A--with photodynamic therapy with verteporfin in the treatment of predominantly classic ...
ANCHOR, Study Group, Brown, DM, Kaiser, PK, Soubrane, G, Michels, M, Schneider, S, Heier, JS, Kim, RY, Sy, JP, Wolf, Sebastian   +9 more
core   +1 more source

Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity

, 2007
Purpose: To evaluate neuroretinal function and anatomical outcomes in patients with neovascular age-related macular degeneration (AMD) after three treatments with ranibizumab.\ud \ud Design: Observational case reports.\ud \ud Methods: We investigated ...
Greaves, Amanda, Feigl, Beatrix, Brown, Brian   +2 more
core  

Outcomes of Intravitreal Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration in Kazakhstan. [PDF]

Vision (Basel)
Suleimenov M, Kadyrgaliyev B, Kanafyanova E, Meyermanova Z, Abdullina V, Zhankalova Z, Yeshmanova A, Abdykulova A, Almukhambetova S, Kulmaganbetov M.   +9 more
europepmc   +1 more source

Changes in expression of DNA-methyltransferase in neovascular age-related macular degeneration: Anti-VEGF response or disease severity? [PDF]

Am J Ophthalmol Case Rep
Camacho P, Ribeiro E, Pereira B, Nascimento J, Rosa PC, Henriques J, Barrão S, Afonso J, Delgadinho M, Ginete C, Brito M, Cabral D.   +11 more
europepmc   +1 more source